Significant Ownership of OrbiMed Israel BioFund GP Limited Partnership

Signature - Title
/s/ Carl L. Gordon - Carl L. Gordon/Director
Location
Herzliya
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by OrbiMed Israel BioFund GP Limited Partnership.

Notify me when OrbiMed Israel BioFund GP Limited Partnership files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of OrbiMed Israel BioFund GP Limited Partnership

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CMMB Chemomab Therapeutics Ltd. Ordinary Shares, no par value. American Depository Shares, each of which represents twenty Ordinary Shares, no par value 4.8% $1,183,165 969,807 ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP 18 Jun 2025
PHGE BiomX Inc. Common stock, par value $0.0001 per share 1% 276,150 ORBIMED ISRAEL GP LTD. 18 Jun 2025

Schedules 13D/G Reported by OrbiMed Israel BioFund GP Limited Partnership:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.